\begin{table}[htbp]\centering
\def\sym#1{\ifmmode^{#1}\else\(^{#1}\)\fi}
\caption{Summary statistics for selected variables}
\begin{tabular}{l*{2}{cc}}
\hline\hline
                    &\multicolumn{2}{c}{All trials}&\multicolumn{2}{c}{US trials}\\
                    &        Mean&Observations&        Mean&Observations\\
\hline
Uses biomarker      &      0.4092&     131,971&      0.4619&      49,540\\
Generous PPM        &      0.0643&     131,971&      0.0907&      49,540\\
Restrictive PPM     &      0.0581&     131,971&      0.0813&      49,540\\
Biomarker role: disease&      0.0842&     131,971&      0.1145&      49,540\\
Biomarker role: toxic effect&      0.0496&     131,971&      0.0699&      49,540\\
Biomarker role: therapeutic effect&      0.3371&     131,971&      0.3758&      49,540\\
Biomarker role: not determined&      0.0023&     131,971&      0.0024&      49,540\\
Biomarker type: anthropomorphic&      0.0350&     131,971&      0.0400&      49,540\\
Biomarker type: biochemical&      0.1248&     131,971&      0.1300&      49,540\\
Biomarker type: cellular&      0.0308&     131,971&      0.0424&      49,540\\
Biomarker type: genomic&      0.2321&     131,971&      0.2845&      49,540\\
Biomarker type: physiological&      0.0849&     131,971&      0.0865&      49,540\\
Biomarker type: proteomic&      0.2426&     131,971&      0.2942&      49,540\\
Biomarker type: structural (imaging)&      0.0177&     131,971&      0.0200&      49,540\\
Biomarker role (detailed): diagnosis&      0.2948&     117,180&      0.3448&      43,777\\
Biomarker role (detailed): differential diagnosis&      0.1829&     117,180&      0.2041&      43,777\\
Biomarker role (detailed): predicting drug resistance&      0.0624&     117,180&      0.0778&      43,777\\
Biomarker role (detailed): predicting treatment efficacy&      0.2568&     117,180&      0.3060&      43,777\\
Biomarker role (detailed): predicting treatment toxicity&      0.0474&     117,180&      0.0493&      43,777\\
Biomarker role (detailed): screening&      0.0523&     117,180&      0.0547&      43,777\\
Biomarker role (detailed): selection for therapy&      0.0938&     117,180&      0.1111&      43,777\\
Biomarker role (detailed): disease profiling&      0.1909&     117,180&      0.2269&      43,777\\
Biomarker role (detailed): monitoring disease progression&      0.1293&     117,180&      0.1394&      43,777\\
Biomarker role (detailed): monitoring treatment efficacy&      0.2998&     117,180&      0.3481&      43,777\\
Biomarker role (detailed): monitoring treatment toxicity&      0.0464&     117,180&      0.0469&      43,777\\
Biomarker role (detailed): not determined&      0.0090&     117,180&      0.0114&      43,777\\
Biomarker role (detailed): prognosis&      0.2375&     117,180&      0.2797&      43,777\\
Biomarker role (detailed): prognosis - risk stratification&      0.0564&     117,180&      0.0660&      43,777\\
Biomarker role (detailed): risk factor&      0.2407&     117,180&      0.2770&      43,777\\
Biomarker role (detailed): staging&      0.1103&     117,180&      0.1280&      43,777\\
Biomarker role (detailed): toxicity profiling&      0.0085&     117,180&      0.0082&      43,777\\
Phase 1 Clinical (includes Phase 1/Phase 2 trials)&      0.3305&     131,971&      0.3653&      49,540\\
Phase 2 Clinical (includes Phase 2/Phase 3 trials)&      0.4367&     131,971&      0.4263&      49,540\\
Phase 3 Clinical    &      0.2328&     131,971&      0.2083&      49,540\\
Drug indication for neoplasm&      0.3343&     131,971&      0.3994&      49,540\\
Received NIH funding&      0.0282&     131,971&      0.0703&      49,540\\
Trial site in US    &      0.4368&     113,410&      1.0000&      49,540\\
\hline
N                   &     131,971&            &      49,540&            \\
\hline\hline
\end{tabular}
\end{table}
